
Hepatocellular carcinoma is the most common type of liver cancer. It is an aggressive (fast-growing) cancer that most commonly affects persons with severe liver disease, such as cirrhosis. People with HCC are increasingly being diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD), which can develop to cirrhosis.
Tumours may not present symptoms in their early stages. However, as HCC proceeds, you may notice:
Causes
Risk Factors
The following conditions enhance your risk of developing HCC:
There are various ways to lower your chance of having HCC. You can do:
Surgery: The surgical treatments for HCC are hepatectomy (removal of the diseased section of the liver) or liver transplantation.
Cost Start From USD 45000 - USD 60000Explore Options
Ablation therapy: This involves the use of a specialised needle to burn malignancies. The needle can direct highly hot energy (microwaves or radiofrequency waves) or extremely cold.
Embolisation: It is the process of implanting a material directly into the arteries that supply the tumour, blocking blood flow.
Radiation therapy: Providers may recommend radiation therapy to treat tiny cancers that cannot be removed surgically or destroyed through ablation.
Immunotherapy: Immunotherapy drugs are also used to treat advanced HCC. They help your immune system recognise and combat cancer cells.
Cost Start From USD 3000 - USD 13578Explore Options
Targeted therapy: These medications treat advanced HCC. This medication inhibits the signal that tells cancer cells to continue growing.
Cost Start From USD 3500Explore Options
Rehabilitation treatments for Hepatocellular Carcinoma (HCC) aim to increase quality of life, accelerate physical recovery, and minimise therapeutic side effects. Here are the main rehabilitation alternatives for HCC patients:
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.
Treatment regimens are adapted to the patient's specific cancer stage and location.









Bangkok, Thailand
Phyathai 2 International Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Bangkok, Thailand
Bangpakok 9 International Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Bangkok, Thailand
Bangkok Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing Thailand:
Yes, liver transplantation is a potential therapeutic option for Hepatocellular Carcinoma (HCC) in Thailand, particularly for patients with early-stage malignancy, tumours localised to the liver, and cirrhosis. Thailand has several reputed transplant centres that do liver transplants with success rates, ensuring thorough care throughout the process.
Hepatocellular Carcinoma (HCC) is treated effectively in Thailand, especially when diagnosed early. Thailand's hospitals achieve excellent patient outcomes by using advanced therapies.
The country's cutting-edge technologies, trained specialists, and comprehensive treatment programs all help to increase survival rates and improve the quality of life for people receiving HCC treatment.
Survival rates vary depending on the stage of diagnosis. Early-stage HCC treated with surgery or liver transplantation has a much greater survival rate; however, advanced cases may have a poorer survival rate despite treatment. Early diagnosis and treatment significantly enhance outcomes.
Yes, lifestyle changes include:
Yes, hepatocellular carcinoma (HCC) is relatively common in Thailand, owing to the high incidence of chronic liver illnesses such as hepatitis B and C infections, both of which are key risk factors for HCC. Cirrhosis, which can lead to liver cancer, is another major issue in the country. As a result, early detection and treatment of HCC are essential for better outcomes.
Many patients can maintain a high quality of life because to improved therapies such surgery, liver transplants, and personalized medications. However, the disease's impact varies according to cancer stage and treatment options.